Natural Compound Found in Food May Improve Vaccine Response in Elderly
A clinical study from the University of Oxford demonstrates that the natural compound spermidine, found in common foods, can rejuvenate aging immune systems. This dietary supplement significantly improved antibody response and cellular health in older adults who previously showed poor responses to vaccines.

Highlights
- •Spermidine, a natural compound in foods like broccoli and chickpeas, improves vaccine response in the elderly.
- •A study of 40 volunteers over age 65 showed improved antibody production after 13 weeks of supplementation.
- •The compound works by activating autophagy, an essential cellular process that repairs and cleans immune cells.
- •Results indicated that participants with the weakest initial immune responses benefited most from the daily treatment.
A ground-breaking study has revealed that a natural compound found in common food items could significantly boost the effectiveness of a vaccine among elderly populations. Research conducted by experts at the University of Oxford suggests that spermidine, a molecule present in foods like lentils, chickpeas, broccoli, mushrooms, and certain cheeses, helps counteract the natural decline of immune function associated with aging.
Enhancing Immune Response with Spermidine
As individuals grow older, their immune systems gradually lose efficacy, a process often referred to as immunosenescence. This decline frequently leads to a weaker response to vaccines, resulting in lower antibody production compared to younger age groups. To investigate potential interventions, researchers led by Katya Simon and Ghada Al-Saleh tested whether daily supplementation of spermidine could improve these critical immune functions.
The clinical trial involved 40 healthy volunteers aged 65 and older who had already received three doses of the COVID-19 vaccine. Over a 13-week period, half of the participants were given a daily spermidine supplement, while the remainder received a placebo. The study found the supplement to be safe and well-tolerated, with no adverse side effects reported.
The results were particularly striking for the approximately 25% of participants who initially showed a very poor immune response to their prior vaccinations. Those individuals exhibited clear markers of biological aging in their immune cells, including increased DNA damage. Following the spermidine regimen, these specific participants showed a notable rise in SARS-CoV-2 antibody levels and improved B-cell functionality. Their immune systems demonstrated a heightened ability to neutralize various viral strains effectively.
Researchers believe the compound functions by stimulating autophagy—a natural cellular recycling process that removes damaged components and maintains cellular health. By promoting this internal maintenance, the compound helps reduce the hallmarks of immune aging, potentially offering a simple, dietary-based approach to strengthening long-term protection provided by a vaccine.
This collaborative study involved the Kennedy Institute of Rheumatology, the Oxford Vaccine Group, and Cardiff University. It was supported by the UK Arthritis Foundation and Wellcome Trust, marking a significant step toward improving health outcomes for the elderly.













